Chemours Company (CC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 5,808,000 | 5,782,000 | 6,078,000 | 6,831,000 | 6,345,000 |
| Cost of Goods | 4,906,000 | 4,640,000 | 4,776,000 | 5,215,000 | 4,964,000 |
| Gross Profit | 902,000 | 1,142,000 | 1,302,000 | 1,616,000 | 1,381,000 |
| Operating Expenses | 966,000 | 823,000 | 1,547,000 | 844,000 | 705,000 |
| Operating Income | -64,000 | 319,000 | -245,000 | 772,000 | 676,000 |
| Interest Expense | 269,000 | 263,000 | 208,000 | 163,000 | 185,000 |
| Other Income | 56,000 | 50,000 | 135,000 | 132,000 | 185,000 |
| Pre-tax Income | -277,000 | 106,000 | -318,000 | 741,000 | 676,000 |
| Income Tax | 109,000 | 37,000 | -66,000 | 163,000 | 68,000 |
| Net Income Continuous | -386,000 | 69,000 | -252,000 | 578,000 | 608,000 |
| Minority Interests | N/A | N/A | 1,000 | N/A | N/A |
| Net Income | $-386,000 | $69,000 | $-253,000 | $578,000 | $608,000 |
| EPS Basic Total Ops | -2.57 | 0.46 | -1.70 | 3.72 | 3.69 |
| EPS Basic Continuous Ops | -2.57 | 0.46 | -1.69 | 3.72 | 3.69 |
| EPS Diluted Total Ops | -2.57 | 0.46 | -1.70 | 3.65 | 3.60 |
| EPS Diluted Continuous Ops | -2.57 | 0.46 | -1.69 | 3.65 | 3.60 |
| EPS Diluted Before Non-Recurring Items | 0.95 | 1.21 | 2.82 | 4.66 | 4.00 |
| EBITDA(a) | $287,000 | $679,000 | $73,000 | $1,072,000 | $1,002,000 |